Loading…
Loading…
IVRO does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for IVRO and 80,000+ other tickers.
See exactly how IVRO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for IVRO and 80,000+ other tickers.
Established in 1985 and headquartered in Placentia, California, InVitro International specializes in creating and supplying non-animal testing kits to markets both within the United States and globally. Key among their offerings is the Irritection Assay System, an in vitro diagnostic tool designed to identify, categorize, and forecast the potential for eye and skin irritation across a broad spectrum of items, including cosmetics, general consumer products, pharmaceuticals, and various chemical raw materials. They also provide Corrositex, another in vitro test specifically for determining…
Placentia, California--(Newsfile Corp. - August 11, 2026) - Today, InVitro International (OTCQB: IVRO) reported FY '26 Q3 sales of $117,760, off 24.1% from the same period in FY '25. YTD sales of $567,200, reversing 2Q trends, are now 15.9% below the same period in FY '25.
Placentia, California--(Newsfile Corp. - May 5, 2026) - Today, InVitro International (OTCQB: IVRO) reported FY '26 Q2 sales of $206,840, up 5.3 % over the same period in FY '25. YTD sales of $389,440 are now 11.6% below half FY '25.
Placentia, California--(Newsfile Corp. - February 11, 2026) - Today, InVitro International (OTCQB: IVRO) reported undefined quarter FY '26 sales of
Placentia, California--(Newsfile Corp. - December 9, 2025) - Today, InVitro International (OTCQB: IVRO) reported FY '25 sales of $878,937, up 8.3% over FY '24. Net income of $121,980 advanced 14.3% for the same period.
Placentia, California--(Newsfile Corp. - August 5, 2025) - Today, InVitro International (OTCQB: IVRO) reported FY '25, Q3 sales of $234,430, up 39.7% over the same period in FY '24. YTD sales of $675,080 are now 14.4% ahead of FY '24.